BALAXI PHARMACEUTICALS LIMITED (BALAXI) — Cash Flow Reinvestment Rate
BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a Cash Flow Reinvestment Rate of 0.83x as of September 2025, reinvesting Rs123.88 Million (capex Rs123.88 Million ) from operating cash flow of Rs149.66 Million. Check BALAXI PHARMACEUTICALS LIMITED (BALAXI) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
BALAXI PHARMACEUTICALS LIMITED Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for BALAXI PHARMACEUTICALS LIMITED across 6 annual periods. Explore BALAXI PHARMACEUTICALS LIMITED (BALAXI) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for BALAXI PHARMACEUTICALS LIMITED (2013–2024)
Year-by-year capital reinvestment analysis for BALAXI PHARMACEUTICALS LIMITED. For live market cap and broader valuation context, see market cap of BALAXI PHARMACEUTICALS LIMITED.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.54x | Rs26.16 Million | Rs48.66 Million | Rs15.69 Million | ▼ -87.2% |
| 2023 | 4.20x | Rs255.45 Million | Rs60.75 Million | Rs149.80 Million | ▲ +366.7% |
| 2022 | 0.90x | Rs307.61 Million | Rs341.44 Million | Rs273.44 Million | ▼ -100.0% |
| 2021 | 1926.71x | Rs59.73 Million | Rs31.00K | Rs25.56 Million | ▲ +13694722.6% |
| 2015 | 0.01x | Rs29.72K | Rs2.11 Million | Rs29.72K | — |
| 2013 | 0.00x | Rs0.00 | Rs3.25 Million | Rs0.00 | — |